ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON

27 August 2016 (11:35 - 11:55)
Organised by:
Congress Presentation Part of: Controversies in heart failure Pathophysiology and diagnosis ESC Premium Access ESC Congress 2016